Related Experiment Video
Updated: Oct 16, 2025
07:26
Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /T1Magnetic Resonance Imaging
Published on: November 20, 2018
6.6K
Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents
He Wei1, Agata Wiśniowska2, Jingxuan Fan1
1Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139.
Summary
Researchers developed single-nanometer iron oxide (SNIO) particles for MRI. These potent, small nanoparticles enhance MRI signals significantly, offering a new platform for biomedical imaging and diagnostics.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Medical Imaging
Background:
- Magnetic nanoparticles are effective MRI contrast agents but their large size limits applications.
- Probing cellular and molecular phenomena requires contrast agents with better tissue penetration.
Purpose of the Study:
- To develop novel, small-sized magnetic nanoparticles for enhanced MRI.
- To evaluate the performance of single-nanometer iron oxide (SNIO) particles as MRI contrast agents.
Main Methods:
- Synthesized single-nanometer iron oxide (SNIO) particles with superparamagnetic properties.
- Assessed SNIO particle hydrodynamic diameters and MRI signal enhancement (T1-weighted).
- Investigated SNIO particle diffusion in biological tissues and brain uptake after blood-brain barrier disruption.
Main Results:
- SNIO particles exhibited hydrodynamic diameters comparable to small imaging agents.
- Achieved over 10-fold greater per-molecule longitudinal relaxation enhancement than gadolinium agents.
- Demonstrated effective tissue permeation and brain entry following ultrasound-induced blood-brain barrier disruption.
Conclusions:
- SNIO particles offer a potent MRI contrast platform combining nanoscale material advantages with small-molecule agent properties.
- SNIOs show promise for advanced biomedical applications, including enhanced diagnostics.
- This technology provides a new avenue for MRI probe development.
